Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient

Liver Transplantation

Volumn 11, Issue 4, 2005, Pages 463-466

  Jonetzko, Patrycja ^a   Graziadei, Ivo ^a   Nachbaur, Karin ^a   Vogel, Wolfgang ^a   Pankuweit, Sabine ^b   Zwick, Ralf ^a   Pachinger, Otmar ^a   Poelzl, Gerhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUINDOSTATIN; URSODEOXYCHOLIC ACID;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG BLOOD LEVEL; DYSPNEA; ELECTROCARDIOGRAPHY; ERYTHEMA INFECTIOSUM; FATALITY; FATIGUE; FEMALE; FORWARD HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MYOCARDITIS; PARVOVIRUS; PRIORITY JOURNAL; RECIPIENT;

ACUTE DISEASE; AGED; DNA, VIRAL; FATAL OUTCOME; FEMALE; GENOME, VIRAL; HUMANS; LIVER TRANSPLANTATION; MYOCARDITIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POSTOPERATIVE COMPLICATIONS; SHOCK, CARDIOGENIC;

EID: 17344364046     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20375     Document Type: Article

References (17)

1. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, Kramer MR. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388-1392.
2. Bowles NE, Vallejo J. Viral causes of cardiac inflammation. Curr Opin Cardiol 2003;18:182-188.
3. Shah SS, McGowan JP. Rickettsial, ehrlichial and Bartonella infections of the myocardium and pericardium. Front Biosci 2003;8:e197-e201.
4. Wasi F, Shuter J. Primary bacterial infection of the myocardium. Front Biosci 2003;8:s228-e231.
5. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 2:151-153.
6. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350: 586-597.
7. Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B. Prevalence of parvovirus B19 genome in endomyocardial biopsy specimen. Hum Pathol 2003;34:497-503.
8. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001;5: 320-330.
9. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997;96: 3549-3554.
10. Lamparter S, Schoppet M, Pankuweit S, Maisch B. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol 2003;34:725-728.
11. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, et al. Parvovirus B19 infection mimicking acute myocardial infection. Circulation 2003;108:945-950.
12. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. The immune response to B19 parvovirus infection and an antibody defect in persistent viral infection. J Clin Invest 1989; 84:1114-1123
13. Lower FE, Menon S, Sanchez JA. Association of parvovirus B19 with plasma cell-rich myocardial infiltrates after heart transplantation. J Heart Lung Transplant 2001;20:755-758.
14. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-117.
15. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000 343:1388-1398.
16. Maisch B, Ristic AD, Hufnagel G, Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002;11:112-122.
17. Stouffer GA, Sheahan RG, Lenihan DJ, Patel P, Lenihan DJ. The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin. Am J Med Sci 2003;326:369-374.